Inventor · Montréal, QC, CA

Adel Rafai Far

12Patents
2h-index
20Co-inventors
50Inventor score

Filing activity: Aug 11, 2006 → Jun 11, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US9295687B1 Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Performing Operations; Transporting 3 Active
US9439921B2 Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Performing Operations; Transporting 2 Active
US8524691B2 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections Human Necessities 2 Active
US9700575B2 Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Performing Operations; Transporting 1 Active
US10039780B2 Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same Performing Operations; Transporting 1 Active
US8404664B2 Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections Human Necessities 0 Active
US8946144B2 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections Human Necessities 0 Active
US10864249B2 High purity oritavancin and method of producing same Chemistry; Metallurgy 0 Active
US8901072B2 Glycopeptide and lipoglycopeptide antibiotics with improved solubility Human Necessities 0 Active
US10201587B2 Methods of inhibiting and treating biofilms using glycopeptide antibiotics Human Necessities 0 Active
US10328118B2 High purity oritavancin and method of producing same Chemistry; Metallurgy 0 Active
US9649352B2 High purity oritavancin and method of producing same Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.